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ABSTRACT 
Lumbar disc degeneration (LDD) is a common musculoskeletal condition. Genetic risk factors 
have been suggested to play a major role in its etiology. The following article reviews the main 
research strategies that have been used to study the genetics of LDD, and the genes that thus far 
have been identified to influence susceptibility to LDD. With the rapid progress in genomic 
technologies, further advances in the genetics of LDD are expected in the next few years. 
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Introduction 
 Low back pain (LBP) is a common musculoskeletal disorder and a global burden. 
Approximately 70-80% of people have experienced LBP at some point in their life.1 The 
annual prevalence of LBP ranges from 15% to 45%, but is largely dependent on population 
under study and surveillance methods 1,2. Low back pain can lead to diminished function, loss 
of productivity, loss of work, and psychological distress, and increased health-care costs. As 
such, LBP poses considerable financial burden to nations through the direct cost spent on LBP 
treatments and the indirect cost due to loss in working productivity.3,4 In fact, in United States, 
one of the most frequent reasons for medical consultation is LBP 1,3,4. Therefore, the impact of 
LBP upon society is substantial and understanding of its development is imperative (see article 
by Karppinen et al). 
 Although LBP is a prevailing disorder, the factors that contribute to LBP are still not fully 
understood. Indeed a variety of factors, such as occupation, biopsychological factors, 
cardiovascular disorders,  smoking, and obesity among others  have been suggested to be 
associated with LBP 5-9. Conversely, British twin studies showed that there is excessive 
concordance of LBP for monozygotic (MZ) twins over dizygotic (DZ) twins, resulting in 
heritabilities ranging from 52% to 68% for various LDD phenotypes 10. In addition, according 
to a study by Battie et al 11 consisting of Finnish Twins noted that heritability estimates ranged 
from 30% to 39% for various definitions of back pain problems over the prior year. Apparently, 
genetic factors play a vital role to the aetiology of LBP. 
 Intervertebral disc (IVD) degeneration is one proxy by which genetic risk factors act to 
influence LBP10,11.This is revealed by studies that found IVD degeneration to be associated 
with LBP 11-20. Although LBP is a multifactorial condition, discogenic origin can be mediated 
by such mechanisms as nerve in-growth in degenerated discs, nerve root compression from 
herniated discs and inflammatory responses of surrounding tissues in response to disc 
pathology 11,21. Due to the close relationship between LBP and LDD and the fact that both LDD 
and LBP have a large genetic component in their etiology, it is worthwhile to investigate the 
genetics of LDD to unveil the mechanism by which LDD and thus LBP develop.  Thus, the 
purpose of this article is to discuss and raise awareness of genetics factors related to LDD. 
Furthermore, this article will also address the genetic-based technologies, methodologies and 
study designs that have been developed to assess LDD. 
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Genetic Component of Lumbar Disc Degeneration  
 The first step in studying genetics of a condition is to ask to the following -- is there a 
genetic component for a disease or its symptoms ? The initial step in approaching this issue is 
to determine if there is familial aggregation, that is if a relatively higher number of 
occurrences exist of diseased individuals among family members than in that of non-diseased 
individuals. On that basis, various studies were carried out to decipher if familial aggregation is 
indeed present in LDD. Varlotta et al 22 found that in adolescent patients with disc herniation 
that a larger proportion of individuals had a positive family history of disc herniation than in 
control subjects. This finding was subsequently further supported by other investigators, such 
as  Frino et al 23 and Matsui et al 24. According to a study by Postacchini and colleagues 25 
consisting of discogenic LBP patients, the authors noted a large proportion of first relatives that 
had experienced discogenic LBP and who undergone disc surgery. Moreover, based on a study 
by Simmons et al, 26 patients who had undergone spine surgery had a greater frequency of 
relatives having experienced LBP and sciatica. Other reports have also noted a positive family 
history of LBP 27 and disc degeneration 28,29 in spine surgery patients. In short, these reports 
and others  have indicated the presence of familial aggregation for LDD and as such the 
possibility of a genetic component influence on LDD. 
 Although studies have illustrated an association between familial aggregation and LDD, 
they only suggest a "possibility" of a genetic component. The reason being is that we still need 
to differentiate between familial aggregation that is due to social-behavioural factors from that 
attributed to genetic factors. This can be achieved through twin studies in which assess 
differences in disease concordance rates between MZ twins and DZ twins. If there is a strong 
genetic background for a disease, MZ twins should have a greater concordance rate in disease 
status than do DZ twins. From the twin studies, heritability, defined as the proportion of a 
population's phenotypic differences due to genetic variation, can be estimated. In 1995, based 
on 155 identical male twins of the Finnish Twin Spine Study, Battie et al 30 found that genetic 
risk factors play a major role in the development of LDD as noted on magnetic resonance 
imaging (MRI), explaining 77% of the variability. Soon thereafter in 1999 and based on UK 
Twin Study, Sambrook et al31assessed LDD based on MRI of 172 MZ twins and 154 DZ twins, 
and noted a 74% heritability rate of LDD. The findings from these seminal studies based on 
Finnish and UK twins greatly substantiated the role of genetics as an etiological risk factor in 
the development of LDD. 
 Although the importance of genetics can be established, there are two interesting points to 
note. First, there is no single gene alone that is substantial for causing LDD. Based on a study 
by Livshits et al 32 assessing an Arabic pedigree, the authors reported that a family history was 
found to be a risk factor for the development of LDD. Interestingly, a simple monogenic 
Mendelian pattern of inheritance was rejected, suggesting that there could be a more complex 
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mode of inheritance for LDD involving multiple genes. Secondly, genetic factors may interact 
with environmental factors in the etiological framework of LDD. For example, based on early 
reports of the Finnish Twin Study,  cigarette smoking status was found to greatly increase the 
ability of predicting LDD.33. Therefore, since gene-environment interaction effects may be 
present and oftentimes may be complex to disseminate, this presents a challenge to the 
“hunting down” of the disease mechanism of LDD. 
 
Defining the Phenotype of Disc Degeneration 
 Throughout the years, the integrity of the intervertebral discs has been assessed by various 
imaging modalities, such as plain radiographs, discography, computed tomography (CT) and 
MRI.34-38. Standing plain radiographs or x-rays are commonly utilized to assess disc space 
height and sclerosis of the endplate as well as other spinal and alignment abnormalities; 
however, this imaging lacks the ability to assess the soft tissue of the disc. Discography entails 
injection of provocative material directly into the disc to identify discogenic origin of the pain 
source; however, this methodology is oftentimes uncomfortable to the individual and may 
accelerate LDD due to the direct disc injury that may be induced by the needle puncture.39 
Computed tomography is a method widely used for chest and abdominal imaging. However, it 
is less useful for examining soft tissues of this disc and is associated with excessively 
high-levels of ionizing radiation exposure. Since the hallmark of disc degeneration entails the 
loss of water and proteoglycan content in the nucleus pulposus with structural changes of the 
disc and adjacent endplate (see article by Chan et al), this process entails various stages of 
degeneration that are best assessed with imaging sensitive to such alterations. As such, MRI is 
a non-invasive method of imaging that allows direct evaluation of the soft tissues of the disc 
and as such is a desirable method, or rather a more sensitive method than the alternative 
imaging modalities, for intervertebral disc imaging in assessing the phenotype of LDD. 
Throughout the years, MRI technology has further been developed to assess the integrity of the 
disc in a more sensitive and quantitative manner (see article by Majumdar et al).  
Nonetheless, due to the variety of imaging modalities in existence and the presence of 
numerous classification schemes in assessing disc degeneration, this has in fact posed a 
dilemma in adopting a universal methodology to assess the phenotype of LDD.13,40 Therefore,  
tremendous heterogeneity exists in the imaging phenotype of LDD between various 
observational cohort and genetic studies.  
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Integration of Knowledge of the Human Genome for Genetic Studies 
 The study of genetics was pioneered by Gregor Mendel who developed Mendel’s laws of 
genetics that allowed us to relate differences in genetic material (i.e. DNA) of organisms to 
appearances or conditions that are observable (i.e. phenotypes). Two major factors have 
propelled genetics even further: our knowledge of the all the variants present in our genome, 
and the advancement in capturing these variations, or genotyping, technologies.  
 Each unit of DNA consist of an alkaline structure, known as a base pair. Single nucleotide 
polymorphisms (SNPs) are single base-pair changes among individuals. Microsatellites are 
short repeated DNA fragments. Copy number variations (CNVs) are longer (> 1 kb, kilo base 
pair) DNA fragments that have a different number of copies compared with a reference 
genome. Before the first decade of the 21st century genetic studies mainly focused on 
microsatellite and SNP markers. Nowadays, considerable attention has been given to the 
importance of CNVs. Presently, in comparison with SNP and CNVs, microsatellites are 
relatively seldom used for genetic studies.  
 
Genome Projects for Human Genetics 
 Improvements in genotyping technologies have enriched our knowledge of the 
relationship between genetic sequence and disease. The large-scale study of this relationship 
was made possible by the Human Genome Project 41, which provided the first reference human 
genome sequence. Later on, the HapMap project was initiated, with the main goal of capturing 
the pattern of SNPs, the most common type of genetic variation among individuals, within the 
human genome 42,43. The initial stages of the project included Yoruban individuals from Africa, 
Caucasian individuals from the United States, Chinese, and Japanese individuals. Around 3.1 
million SNPs were successfully genotyped 42. The success of the HapMap project was a big 
step forward in supporting genetic studies. It helped us understand the linkage disequilibrium 
(LD) pattern  within the human genome, enabling us to choose only one or a small number of 
“tagging” SNPs within a high LD (low recombination rate) region to genotype to obtain almost 
complete common variant information on a particular genomic region. This process helps save 
a huge amount of resources for genetic studies. Recently, the 1000 Genome Consortium has 
completed its initial sequencing of 179 individuals 44, signifying the next era of genetic studies, 
which is consists of sequencing each base-pair of DNA -- known as “deep resequencing” as 
opposed to genotyping, which captures only known varying regions of genome. In terms of 
disease genetic study, sequencing information enables us to study rare and previously unknown 
sequence variants. The 1000 Genome Project data are also valuable to allow us to “predict” the 
genotypes of SNPs not genotyped in the actual experiment by a computational process known 
as imputation 45. With the denser map, locations of disease-causing variants can be determined 
with more precision. 
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Genotyping Technologies 
 Modern genotyping technologies can be divided into two main categories: (1) those that 
are suitable for genotyping a larger number of SNPs and are thus suitable for genome-wide 
association studies (GWAS), and (2) those that are optimal for large samples size and are thus 
suitable for replication studies 46. The most popular GWAS genotyping platforms are Ilumina’s 
Infinium BeadChip and Affymetrix GeneChip, while other assays such as Perlegen and 
Invader are also available 46. Illumina BeadChip and Affymetrix GeneChip are now capable of 
genotyping over 1 million SNPs and CNVs in the genome. Because of the design of the 
products, Illumina BeadChip has a higher genomic coverage, meaning that the SNPs of the 
product is more capable of capturing information of the genome 47. However, both Affymetrix 
and Illumina, can also be used for genotyping smaller, more confined genotypic regions. 
 Sequenom MassArray is one platform used for a larger sample number with a small 
number of SNPs. I-plex assays for MassArray can be used for genotyping up to 40 SNPs. 
Alternatively, Taqman assay (from Applied Biosystems) uses a real-time PCR-based method 
for SNP detection. Different alleles have different fluorescent probes. Therefore, the detection 
of different alleles can be achieved from signals given by their corresponding probes. The 
accuracy of this assay can reach up to 99% 46. Other genotyping assays, such as 
Pyrosequencing, are also available 48. 
 
 
Main Genetic Study Strategies 
Linkage and association strategies of genetic studies 
 Genetic studies are divided into two main streams: (1) family linkage analysis and (2) 
case-control association approach. In family linkage analysis, the pattern of inheritance of a 
disease is compared with the pattern of disease markers. If a particular region of markers can be 
observed to be inherited in the same way as the disease, then the disease causing variant may lie 
within the region. Family data are required for carrying out linkage studies. 
In the case-control association approach, unrelated individuals with extreme disease statuses, 
namely, the case group (those with the phenotype) and the control (those without the phenotype) 
group, are recruited. The allele frequencies of the genetic variants between cases and controls 
are compared. Disease-causing variants are identified by searching for markers that show 
statistically significant differences in allele frequencies between the two groups.  
 Association within family trios can also be carried out using transmission disequilibrium 
test (TDT). This test is conducted by observing in heterozygous parents if there is one allele 
with higher transmission frequency to the offspring than the other 49. This design is 
advantageous than the case-control design in that it avoids false positives caused by the 
differences in population composition between the case and control groups. However, the 
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power of this test is lower than that of the case-control design because the two parents are 
approximately equivalent to only one unrelated control subject in information  49.  
 Depending on the SNP selection strategy, the case-control association approach can be 
divided further into the candidate gene and genome-wide approaches. The candidate gene 
approach has the main advantage that it is more specific, as the selection of SNPs is based on 
the prior knowledge on the biology of the disease. When a high-throughput genotyping 
platform is not so readily available, this approach has been shown to be successful in 
identifying a number of genetic risk variants for some complex diseases. Currently due to the 
availability of whole-genome genotyping platforms, the genome-wide approach for 
association studies has been made possible. The main advantage of this approach is that regions 
of interest need not be confined in particular genomic regions, relying on investigators’ 
knowledge. Therefore, novel genetic variants are more readily identified. 
 
Strengths and weaknesses of linkage and association approaches (Table 1) 
 Linkage studies were attractive at the time when genetic marker maps and genotyping 
technologies allowed few markers to be studied. This is because linkage can be detected over 
long distances from a disease susceptibility locus. Alternatively, an important disadvantage of 
linkage studies is that they are powerful only when the mutation has a very high probability of 
causing disease (high penetrance). Association studies rely on linkage disequilibrium between 
genetic markers and disease susceptibility locus, and this typically requires the two loci to be 
very close to each other. In consequence, association studies were for a long time confined to 
the study of specific candidate genes supported by a strong hypothesis, and a genome-wide 
screen using association was not feasible until the recent developments in genotyping 
technologies mentioned above. An important advantage of association over linkage is that 
association has much greater power to detect a locus with small or modest effect size. However, 
linkage is more robust to allelic heterogeneity, which refers to the presence of multiple risk 
alleles at a locus. With modern sequencing technology, linkage and association are best 
considered to be two complementary ways of using genetic markers to study the genetic basis 
of simple and complex diseases.
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Findings on the Genetics of Lumbar Disc Degeneration 
Candidate gene studies  
 Genetic risk factors of LDD have been quite extensively studied in light of the findings 
from family and twins studies, which show that LDD has a substantial genetic component. 
Several articles have reviewed these genetic risk factors 50-53. Today most of the genetic studies 
of LDD adopted the candidate gene approach. Genetic studies on LDD have focused on the 
genes that code for the functioning molecules in the disc, including the components of collagen 
IX 54-56, aggrecan 57,58, degrading enzymes such as matrix metalloproteinase II 59 and III 60,61, 
inflammatory signaling molecules such as interleukin I (IL-1) 62-64. Other genes identified 
associated with LDD are susceptibility genes related to other diseases. For instance, asporin 65 
was first identified in rheumatoid arthritis 66, osteoarthritis (OA) and knee OA 65,67,68; collagen 
I 69 and vitamin D receptor (VDR) 70-72 are related to osteoporosis (collagen I: 73-75; VDR: 76,77), 
and CILP 78 is found in cartilage 79.  
 However, most of these studies need to be confirmed with a larger sample size or a 
meta-analysis. A linkage study is also being carried out by our group (unpublished). The results 
show that both association and linkage approaches can identify genetic risk factors of LDD. 
 
Current and Future Trends 
 As the field of genetics is rapidly developing, genetic studies on LDD will become more 
comprehensive and more powerful. In the following section, we discuss areas of advancement 
and future trends in genetics of LDD.  
 
Marker selection and analysis 
 Genetic studies on LDD have previously concentrated on the candidate gene approach. 
Although this approach has fulfilled its mission successfully in the past, it is heavily dependent 
on what we know about the disease, making finding novel genes difficult. Therefore, our study 
group has initiated genome-wide linkage and association approaches, to fill the “knowledge 
gap” and lead to the identification of novel genes in relation to LDD. In our linkage study, we 
recruited early-onset LDD patients and their family members for whole-genome linkage scan. 
For our GWAS, we selected individuals with extreme disc degeneration status, after having 
corrected for age. The synergy of the two approaches can help locate genetic risk factors with 
different properties, thus making our knowledge base for the genetics of LDD more complete. 
In the future, the genomes and exomes of individuals are expected to be sequenced with 
next-generation sequencing methodologies, enabling us to look directly for rare variants in 
individuals  and helping us decipher the genetic mechanism related to LDD. 
 Aside from genes that increase the risk of LDD, the focus can be placed in searching for 
protective genes. This broadening of the mind-set will enable us to discover gene sets that may 
influence LDD through other mechanisms. 
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 In terms of statistical methodologies, multivariate approaches are currently being 
developed. These statistical approaches can make use of information from several genetic 
variants and phenotypes. By combing information from different genes, we will be able to 
consider variants within genes as whole or genetic information across different genes. The 
combined effects of different genes can then be considered simultaneously. Moreover, disc 
degeneration phenotypes can be combined similarly. This combination may help us identify if 
certain combinations of genes or phenotypes are related and therefore, share similar pathologic 
mechanisms. Considering the sets of phenotypes and genes can also reduce the number of 
statistical tests required and increase the statistical power. 
 
Study design 
 Most LDD genetic studies are cross-sectional, which means only disease condition at a 
certain time point can be observed. As databases of volunteers develop, a longitudinal study 
approach can be adopted by recruiting the volunteers for a second imaging. The possibility of a 
dynamic assessment of the progression of LDD condition would allow us to investigate the 
influence of genetic risk factors to LDD and validate hypotheses about their effects. 
 
Increasing sample size by international collaboration 
 In genetic studies, statistical power is one of the most important considerations for likely 
success. The most efficient and economic way (from each research centre’s point of view) to 
increase sample size is to combine study results from different research groups. Meta-analysis 
methodologies can directly combine the significance and effects from multiple studies. With 
this method, samples from different collaborators can be virtually combined in a simple way. 
Currently, many of the GWASs are carried out by meta-analysis across different populations. 
This trend is expected to continue for polygenic diseases like LDD, and is probably a good way 
to "ride the wave" of improving technologies. 
 
Summary 
 Genetics plays a role to the etiology of LDD. However it may either exert effect by itself 
or with other environmental factors. Moreover, our knowledge of the genetic risk factors of 
LDD was not yet very complete. In future, together with our knowledge and advancement in 
genotyping technologies, we can extend our study approach in both the directions of finding 
novel genes that is related to LDD, and analyze LDD etiology with other behavioral and 
environmental factors.   
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Table 1: Advantages and disadvantages of various genetic study methodologies 
 
Table was adopted with modification from 80.  here means the methodology has an advantage 
in this aspect, and the opposite for . 
 
Association 
(candidate gene 
approach) 
Association 
(genome-wide 
approach) 
Linkage 
No knowledge of 
gene functions 
required 
   
Localization to 
small genomic 
region 
   
Cost    
Families not 
required    
Not easily 
affected by 
population 
stratification 
   
Power to detect 
common alleles 
(MAFs>5%) of 
modest effect 
   
Power to detect 
rare alleles 
(MAFs<1%) 
   
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